Kirenol exhibits significant anti-inflammatory and immunomodulatory properties, making it valuable in the development of treatments for autoimmune and inflammatory diseases such as rheumatoid arthritis. It helps reduce joint swelling and tissue damage by inhibiting pro-inflammatory cytokines like TNF-α and IL-6. It also shows promising anti-cancer activity by inducing apoptosis in certain tumor cell lines and suppressing cell proliferation, particularly in liver and breast cancer models. Due to its antioxidant effects, kirenol is explored for protecting cells against oxidative stress, which may benefit neurodegenerative conditions and aging-related disorders. Additionally, it has demonstrated antimicrobial and antifungal activities, suggesting potential use in combating resistant microbial strains. Ongoing research focuses on improving its bioavailability and delivery for therapeutic applications.